Zobrazeno 1 - 10
of 32
pro vyhledávání: '"Chung-Liang Li"'
Autor:
Chung‐Liang Li, Cheng‐Che Wu, Jung‐Yu Kan, Fang‐Ming Chen, Ming‐Feng Hou, Chieh‐Han Chuang, Hsin‐I Huang, Fu Ou‐Yang
Publikováno v:
Kaohsiung Journal of Medical Sciences, Vol 38, Iss 3, Pp 277-282 (2022)
Abstract This study aimed to investigate the effectiveness of neoadjuvant chemotherapy in patients with breast cancer in different age groups and evaluate the impact of age group on survival outcome according to different treatment responses. Data we
Externí odkaz:
https://doaj.org/article/b92fcfd606ce4f9e93182749a3cc4056
Autor:
Chia‐Yu Kuo, Jung‐Yu Kan, Chieh‐Ni Kao, Fu Ou‐Yang, Cheng‐Che Wu, Jun‐ping Shiau, Chung‐Liang Li, Ming‐Feng Hou, Shu‐Hung Huang
Publikováno v:
Clinical Case Reports, Vol 9, Iss 10, Pp n/a-n/a (2021)
Abstract NPWT fulfill graft taking in complex breast wounds.
Externí odkaz:
https://doaj.org/article/ce2e54246ebf43b1a371ec064001303b
Publikováno v:
Case Reports in Oncological Medicine, Vol 2018 (2018)
Compartment syndrome may be acute or chronic based on the clinical course and etiology. Here, we report the first known case to be diagnosed with skeletal muscle-derived B-cell lymphoma presenting with chronic compartment syndrome after trauma. A 62-
Externí odkaz:
https://doaj.org/article/f7b43b21b8044dcfa8b7dcd97d333efd
Autor:
Jui-Hung Tsai, Chung-Liang Li, Dah-Cherng Yeh, Chin-Sheng Hung, Chih-Chiang Hung, Chin-Yao Lin, Yao-Lung Kuo
Publikováno v:
Breast Cancer Research and Treatment. 199:47-55
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a04452fb7fc126d377d922460ffc71f1
https://doi.org/10.1007/s10549-023-06867-6
https://doi.org/10.1007/s10549-023-06867-6
Autor:
Fu Ou-Yang, Fang-Ming Chen, Jung-Yu Kan, Chieh-Han Chuang, Ming-Feng Hou, Cheng-Che Wu, Hsin-I Huang, Chung-Liang Li
Publikováno v:
The Kaohsiung Journal of Medical Sciences. 38:277-282
This study aimed to investigate the effectiveness of neoadjuvant chemotherapy in patients with breast cancer in different age groups and evaluate the impact of age group on survival outcome according to different treatment responses. Data were retros
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::55bb4467c2c5c49950df082805578592
https://doi.org/10.1002/kjm2.12475
https://doi.org/10.1002/kjm2.12475
Autor:
Chih-Po Chiang, Li-Chun Kao, Fu Ou-Yang, Chieh-Ni Kao, Chieh-Han Chuang, Fang-Ming Chen, Jung-Yu Kan, Yao-Tsung Yeh, Chung-Liang Li, Ming-Feng Hou, Yi-Chen Lee, Cheng-Che Wu, Jun-Ping Shiau, Chien-Ju Cheng, Shen-Liang Shih, Sin-Hua Moi
Publikováno v:
Experimental & Molecular Medicine
In Western countries, breast cancer tends to occur in older postmenopausal women. However, in Asian countries, the proportion of younger premenopausal breast cancer patients is increasing. Increasing evidence suggests that the gut microbiota plays a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::03870dae87f4affee6888fdce03073da
https://doi.org/10.1038/s12276-021-00686-9
https://doi.org/10.1038/s12276-021-00686-9
Autor:
Chung-Liang Li, Sin-Hua Moi, Huei-Shan Lin, Ming-Feng Hou, Fang-Ming Chen, Shen-Liang Shih, Jung-Yu Kan, Chieh-Ni Kao, Yi-Chia Wu, Li-Chun Kao, Ying-Hsuan Chen, Yi-Chen Lee, Chih-Po Chiang
Publikováno v:
International Journal of Molecular Sciences; Volume 23; Issue 18; Pages: 10539
Endocrine therapy (ET) of selective estrogen receptor modulators (SERMs), selective estrogen receptor downregulators (SERDs), and aromatase inhibitors (AIs) has been used as the gold standard treatment for hormone-receptor-positive (HR+) breast cance
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::30f4f2d5c821a0b3a58219167e801251
Autor:
Fu Ou-Yang, Mei-Ren Pan, Chi-Wen Luo, Shao-Yu Fang, Chin-Ju Ko, Chia-Wei Huang, Ming-Feng Hou, Chung-Liang Li
Publikováno v:
Anticancer Research. 40:5529-5538
Background/aim Triple-negative breast cancer (TNBC) is a unique subtype that lacks expression of several conventional biomarkers and has a higher incidence of lymph node invasion and distal metastasis among all breast cancers. Anoikis resistance is t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8433e7eeeb92aaef75e41a5d3bbc90ed
https://doi.org/10.21873/anticanres.14565
https://doi.org/10.21873/anticanres.14565
Autor:
Fu, Ou-Yang, Chung-Liang, Li, Chia-Chi, Chen, Yi-Chun, Shen, Sin-Hua, Moi, Chi-Wen, Luo, Wei-Ya, Xia, Ying-Nai, Wang, Heng-Huan, Lee, Lu-Hai, Wang, Shao-Chun, Wang, Mei-Ren, Pan, Ming-Feng, Hou, Mien-Chie, Hung
Publikováno v:
Am J Cancer Res
The atezolizumab (Tecentriq), a humanized antibody against human programmed death ligand 1 (PD-L1), combined with nab-paclitaxel was granted with accelerated approval to treat unresectable locally advanced or metastatic triple-negative breast cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::102d9ffee8f36cb8da810c774188b159
https://pubmed.ncbi.nlm.nih.gov/35141008
https://pubmed.ncbi.nlm.nih.gov/35141008
Autor:
Fu Ou-Yang, Shu-Hung Huang, Chia-Yu Kuo, Jung-Yu Kan, Ming-Feng Hou, Cheng-Che Wu, Chung-Liang Li, Chieh-Ni Kao, Jun-Ping Shiau
Publikováno v:
Clinical Case Reports, Vol 9, Iss 10, Pp n/a-n/a (2021)
Clinical Case Reports
Clinical Case Reports
NPWT fulfill graft taking in complex breast wounds.
NPWT fulfill graft taking in complex breast wounds
NPWT fulfill graft taking in complex breast wounds
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::58d1b191d9f0225b729c776bcd40e5f5
https://doaj.org/article/ce2e54246ebf43b1a371ec064001303b
https://doaj.org/article/ce2e54246ebf43b1a371ec064001303b